Skip to main content

Table 4 Overall Survival: Univariate and Multivariate Analyses for All Patients (N = 46)

From: Histone H4 acetylation by immunohistochemistry and prognosis in newly diagnosed adult acute lymphoblastic leukemia (ALL) patients

Patient Characteristic

HR on Univariate Analysis (95% confidence interval with p-value)

HR on Multivariate Analysis (95% confidence interval with p-value)

Histone acetylation (Positive versus negative

0.45 (0.21-0.96), p = 0.038

0.51 (0.23-1.31), p = 0.09

Age (>35 years vs. ≤35 years)

1.81 (0.84-3.91), p = 0.13

2.41 (0.75-7.74), p = 0.14

White blood count (>20,000/μL versus ≤20,000/μL)

1.87 (0.87-4.03), = 0.11

3.36 (0.90-12.5), p = 0.07

Poor risk CG vs. others

1.95 (0.82-4.68), p = 0.13